Mason & Associates »

Vertex Pharmaceuticals Incorporated shares owned by Mason & Associates

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Mason & Associates from 13F filings

Historical chart of Mason & Associates investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Mason & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Mason & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 655 391.64
2022-06-30 $309k 1.1k 281.68
2022-03-31 $286k 1.1k 260.71
2021-12-31 $241k 1.1k 219.69

More positions owned by Mason & Associates

J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Dimensional Etf Trust Us Equity Market (DFUS)
American Centy Etf Tr Intl Eqt Etf (AVDE)
New York Life Investments Et Nyli Ftse Intern (HFXI)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Agency Bond Etf (AGZ)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
American Centy Etf Tr Avantis Emgmkt (AVEM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr Series Trust Bloomberg Sht Te (SJNK)
Vanguard World Comm Srvc Etf (VOX)

View all positions for Mason & Associates

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated